Patient P-01493

Synthetic patientNBL-101 · Day 108 · 65–74 · M · baseline S18Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

18%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S18

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Nutritional resilience-13
Inflammatory activity+12
Toxicity+11
GI instability+9
Treatment adherence+5

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

17.1/100

improving · -2.8 vs previous 14 d

Toxicity

Blood

11.4/100

worsening · +5.4 vs previous 14 d

Sleep quality

Wearable

40.2/100

stable · +1.2 vs previous 14 d

Energy level

Daily log

6.5/10

stable · -0.1 vs previous 14 d

Stress level

Daily log

4.9/10

stable · +0.0 vs previous 14 d

Steps

Wearable

4,647

stable · +151 vs previous 14 d

Adherence

Companion

99.6 %

stable · +1.6 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 86 from the failing basin, 2 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep histamine low
GI +7.1 next day on high-intake days · n 24
Keep alcohol low
GI +5.3 next day on high-intake days · n 18

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+7.1detractor · 95%
Alcohol
+5.3detractor · 95%
Simple carbohydrates
-2.6no signal · 38%
Insoluble fibre
+2.5no signal · 41%
Spicy / capsaicin
-2.1no signal · 30%
Dietary fat load
+1.1no signal · 16%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
Autonomic recovery ↓20
- WearableShort sleep window
Inflammatory signalling ↑15
- WearableHRV 32 ms, trending down

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
CYP2D6 Normal metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3.3 · butyrate capacity 52/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 34 ms
Sleep: 7.0 h
Steps: 5,891
Resting HR: 54 bpm

Daily log: GI score 17, nutritional resilience 62, adherence 100.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01654	48%	S08	CR-01	improved	85
P-01791	45%	S06	ME-01	improved	79
P-01796	45%	S09	SC-12	improved	86
P-01798	44%	S08	NP-02	improved	78
P-01495	43%	S07	BR-03	improved	85
P-01329	42%	S08	BR-03	improved	79
P-01439	42%	S18	ME-01	improved	79
P-01671	40%	S04	SC-12	improved	90
P-01625	38%	S06	SC-12	improved	83
P-01467	36%	S09	HY-01	improved	79
P-01503	36%	S15	ME-01	improved	80
P-01855	35%	S04	DT-01	improved	73